Osteoarthritis Trial, Recruiting NCT04998188 Sponsor: Istituto Ortopedico Rizzoli Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT04998188
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with knee cartilage degeneration affecting only one knee
  • People who have symptoms and physical signs of worn or damaged knee cartilage
  • People whose X-rays and MRI scans show signs of knee cartilage degeneration (graded on a standard scale from 1 to 4)
  • People who have already tried at least one round of non-surgical treatment — such as medication, physiotherapy, or injections — without enough relief from symptoms
  • People who are willing and able to attend follow-up appointments throughout the trial

Who may not be able to join:

  • People who have had an injection of any substance into the affected knee joint in the past 6 months
  • People who have had knee surgery in the past 12 months
  • People who have or have had a malignant cancer
  • People who have a rheumatic disease (such as rheumatoid arthritis or similar conditions)
  • People who have diabetes
  • People who have a blood or clotting disorder
  • People who are currently taking blood-thinning medication
  • People who have a thyroid gland disorder affecting metabolism
  • People with a history of misusing alcohol, drugs, or medications
  • People with a Body Mass Index (BMI) over 35
  • Women who are pregnant or breastfeeding
  • People who have a known allergy or sensitivity to bovine (cow-derived) collagen or vitamin C
  • People who have an active infection, bleeding into the joint, redness, or psoriasis patches in or around the knee area

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alessandro Di Martino, MD, Istituto Ortopedico Rizzoli

Phone: 0516366567

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istituto Ortopedico Rizzoli
Registry
ClinicalTrials.gov
Start date
16 February 2022
Est. completion
1 December 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

KOOS-Pain Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov